An interventional study of Strabismus surgery in Strabismus, Concomitant Squint and Divergent Strabismus, sponsored by Minia University. Completed at 1 site in Egypt. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2022-01-26.
Sponsored by Minia University · Not applicable, Interventional, and Diagnostic
Patients with consecutive exotropia will be managed by medial rectus muscle advancement +/- resection or medial rectus muscle advancement +/- lateral rectus recession
58 studies on the registry are indexed under Exotropia; 13 are open to participants now.
This study's enrollment of 20 is below the median of 50 across 49 interventional studies indexed under Exotropia.
Browse Exotropia studies →Minia University is the lead sponsor of 370 studies on the registry; 117 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Compared within Exotropia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Strabismus. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Surgery will be done to strengthen the medial rectus muscle with resection and anterior displacement again to the original insertion site 5 mm from limbus
Procedure: Strabismus surgery
Surgery will be done to strengthen the medial rectus muscle with anterior displacement again to the original insertion site 4- 5 mm from limbus with weakening procedure to the lateral rectus muscle at the same time
Procedure: Strabismus surgery
Strengthening of medial rectus muscle or strengthening of medial rectus muscle with weakening of the lateral rectus muscle
Percentage of patients with satisfactory postoperative alignment
Efficacy of each surgical procedure and its further effect using prism cover test to access postoperative alignment of the eye
Time frame: 6 months
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.